Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
My69z's Profile
Displaying 351-400 of 1147 result(s).
CYDY CytoDyn Inc
02/24/2025 7:32:26 PM
Addtl MGK just now.... https://stoc (1)
CYDY CytoDyn Inc
02/24/2025 7:29:21 PM
ART stop: 350mg was significant. MA (1)
CYDY CytoDyn Inc
02/24/2025 8:54:48 AM
Right...36 months & still...alive! (3)
CYDY CytoDyn Inc
02/24/2025 8:42:20 AM
Get those "patients" into a prime t (12)
CYDY CytoDyn Inc
02/24/2025 8:34:36 AM
the Company confirmed that a small (7)
CYDY CytoDyn Inc
02/24/2025 7:11:46 AM
From GF $1m -- "..contributing to t (2)
CYDY CytoDyn Inc
02/24/2025 1:10:10 AM
Realize what's happened? Max announ (3)
CYDY CytoDyn Inc
02/23/2025 1:34:33 AM
Gates: Best Bets Hiv cure & Resevoi (14)
CYDY CytoDyn Inc
02/22/2025 3:18:39 PM
We are right @ our entire Hiv portf (5)
CYDY CytoDyn Inc
02/22/2025 3:10:30 PM
" So, yes, LATCH is CytoDyn’s fir (3)
CYDY CytoDyn Inc
02/22/2025 8:15:39 AM
MDR paper / 2023 ART stop & 350mg L (8)
CYDY CytoDyn Inc
02/22/2025 1:49:39 AM
Maraviroc for Stroke: 12/2025 compl (7)
CYDY CytoDyn Inc
02/21/2025 7:04:10 PM
Haha -- was thinking a different wo
CYDY CytoDyn Inc
02/21/2025 4:41:54 PM
bio from ST: GF $1M grant to Dr. Sa (14)
CYDY CytoDyn Inc
02/20/2025 10:49:44 PM
Seems the link works, then dosen't (2)
CYDY CytoDyn Inc
02/20/2025 10:38:54 PM
E. Doug Grindstaff II is big time C (1)
CYDY CytoDyn Inc
02/20/2025 7:26:45 PM
Per WHO, 30m are on ART. Using 10% (5)
CYDY CytoDyn Inc
02/20/2025 7:10:15 PM
ViiV & our PrEP patent application: (6)
CYDY CytoDyn Inc
02/19/2025 1:08:48 AM
Sterilize is cure: Dr. Hanumegowda (4)
CYDY CytoDyn Inc
02/18/2025 9:13:34 PM
On 6/2022 Max defined Hiv "cure". " (4)
CYDY CytoDyn Inc
02/17/2025 7:55:09 PM
Dr. Emily Kansigo on Max's profile, (2)
CYDY CytoDyn Inc
02/15/2025 6:11:32 PM
FDA & our breast cancer: "The FDA F
CYDY CytoDyn Inc
02/15/2025 5:28:05 PM
The most recent stroke patient, a p (14)
CYDY CytoDyn Inc
02/15/2025 4:55:59 PM
Don't forget Oct. 26, 2020: Leronli (1)
CYDY CytoDyn Inc
02/15/2025 12:26:03 AM
3/01/2023 Leronlimab NASH trial: 57 (3)
CYDY CytoDyn Inc
02/13/2025 9:03:55 AM
He needs to go work for GSK as LL p (3)
CYDY CytoDyn Inc
02/13/2025 6:45:33 AM
Glaxosmithkline has no heart scarri (3)
CYDY CytoDyn Inc
02/13/2025 1:00:32 AM
GSK recruiting trials & Exclusions (2)
CYDY CytoDyn Inc
02/12/2025 12:34:03 AM
$400m is 50% less than for some rec (2)
CYDY CytoDyn Inc
02/11/2025 5:57:14 PM
Are we over complicating? GSK/Pfize (7)
CYDY CytoDyn Inc
02/11/2025 3:51:44 PM
Anonymously, fully funded 20 patien (4)
CYDY CytoDyn Inc
02/11/2025 12:00:48 PM
Refractory MSS mCRC enrollment comp (5)
CYDY CytoDyn Inc
02/10/2025 8:51:53 PM
Dr. Mobeen July, 2020 Cytodyn trans (10)
CYDY CytoDyn Inc
02/10/2025 9:24:16 AM
ME/CFS is through NINDS. Not shutdo (1)
CYDY CytoDyn Inc
02/10/2025 9:07:58 AM
NIH RECOVER-LC & (ME/CFS) are Congr (4)
CYDY CytoDyn Inc
02/10/2025 8:59:33 AM
Maybe a multi-faceted consortium of (3)
CYDY CytoDyn Inc
02/09/2025 6:55:21 PM
Cornell IRB meets every 1st Friday. (3)
CYDY CytoDyn Inc
02/09/2025 6:43:26 PM
6/2023: NAFLD/MASH Patent Applicati (4)
CYDY CytoDyn Inc
02/09/2025 8:59:05 AM
& have your little dreams of 90 tim (4)
CYDY CytoDyn Inc
02/08/2025 1:26:03 PM
GF/ViiV(GSK) buys our HIV for a few (5)
CYDY CytoDyn Inc
02/07/2025 9:34:24 AM
Yea, you're right. Mixed it up with (1)
CYDY CytoDyn Inc
02/07/2025 9:14:47 AM
Mother to Child Hiv: Dr. Sacha gran (2)
CYDY CytoDyn Inc
02/06/2025 6:05:07 PM
Today: "....in mice who received a (8)
CYDY CytoDyn Inc
02/06/2025 3:25:00 PM
Woops...Not to remiss on our FcRn, (6)
CYDY CytoDyn Inc
02/06/2025 3:13:21 PM
Bill Gates says breasfeeding is key (15)
CYDY CytoDyn Inc
02/06/2025 8:44:47 AM
To me, reads like Fibrosis, PF & IP (8)
CYDY CytoDyn Inc
02/05/2025 5:19:03 PM
In 2024, the Senate Appropriations (6)
CYDY CytoDyn Inc
02/02/2025 10:05:10 PM
"(although joint or separate MASH d (1)
CYDY CytoDyn Inc
02/02/2025 8:30:54 PM
Glaxosmithkline IPF study -- This w (7)
CYDY CytoDyn Inc
01/28/2025 9:28:21 PM
Now let's get GF/ViiV to human tria (3)
Go to page:
  • << First
  • < Previous
  • 7
  • 8
  • Next >

Recent Articles

  • Ingersoll Rand Strengthens Market Position with New Acquisition
  • Lotus Technology Expands Operations with Strategic Acquisition Deal
  • Horizon Bancorp to Host Earnings Review Call This Month
  • Explore New Horizons in Cloud Mining with FINDMINING
  • Brown & Brown Plans Investor Update for Second Quarter Earnings
  • Unveiling Domino's Pizza's Growth Over Two Decades: A Journey
  • Horizon Bancorp's Upcoming Call to Discuss Q2 Financials
  • Highland Global Allocation Fund Announces Consistent Dividends
  • Highland Opportunities and Income Fund's Upcoming Distribution for Investors
  • Understanding Public Service Enterprise's Market Position Today
  • Eightfold AI Achieves Major Security Milestone in AI Solutions
  • Univest Closes $5 Million Direct Offering with Ostin Tech.
  • PFMCrypto Unveils Revolutionary AI Mining for Passive Income
  • Cidara Therapeutics Announces New Employee Incentive Grants
  • Zentalis Pharmaceuticals Unveils New Stock Options for Growth
  • ROHM's Innovative MOSFET Aims to Transform AI Server Technology
  • Flexible Solutions International Secures $2.5 Million Payment
  • Lotus Technology to Enhance Brand with Full Acquisition of Lotus UK
  • Brown & Brown, Inc. Sets Date for Second-Quarter Earnings Call
  • Plains All American Unveils 2024 Schedule K-3 Details
  • WeightWatchers and Novo Nordisk: A Game-Changer in Care Access
  • Pennant Group Expands Reach with GrandCare Health Acquisition
  • Navitas and Powerchip Collaborate for Advanced GaN Production
  • Lake Shore Bancorp, Inc. Achieves Key Milestone in Reorganization
  • Ingersoll Rand's Strategic Acquisition Enhances Renewable Solutions
  • Clearwater Properties Marks Significant Office Re-Opening Event
  • STAG Industrial Inc. to Release Q2 2025 Results Soon
  • First Industrial Realty Trust Prepares for Q2 2025 Earnings Call
  • American Healthcare REIT to Release Q2 2025 Earnings Soon
  • Centene Corporation Adjusts Financial Guidance Ahead of Changes
  • Upcoming Earnings Call Schedule for Provident Financial Services
  • Deep Sky Advances Global Carbon Tech with $40M Bill Gates Boost
  • O'Reilly Automotive Prepares for Q2 Financial Report Call
  • Centene Corporation Revises 2025 Expectations Amid Changes
  • Robbins LLP Encourages RDDT Investors to Explore Legal Options
  • PNC Financial Services Group's Strategic Capital Management Insights
  • PIMCO Funds Set Monthly Share Distributions for 2025
  • Understanding Capital One's New Stress Capital Buffer Announcement
  • Compass Diversified Faces Class Action Amid Accounting Irregularities
  • M&T Bank Corporation Reports Preliminary Stress Capital Buffer
  • Pennant Group Expands Services with GrandCare Health Acquisition
  • How a Decade of Investing in ICICI Bank Transformed Wealth
  • Guggenheim Investments Reveals Upcoming Fund Distributions
  • Lake Shore Bancorp, Inc. Reveals Special Meeting Outcomes
  • Thornburg Income Builder Trust Reveals Exciting New Distribution Details
  • LENSAR Announces Inducement Grants to New Employees
  • Understanding Seagate Technology's Current Options Trends
  • The Impact of Inflation on Wealth Disparities and Society
  • Exploring Archer Aviation's Options Activity Surge and Trends
  • Chevron's Options Activity: Insights and Market Trends
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site